Can Miromatrix “regenerate” Minnesota’s medical industry? An exclusive interview with Dr. Doris Taylor and Miromatrix CEO Rob Cohen

Miromatrix is close to signing a licensing agreement with the University of Minnesota to commercialize the regenerative tissue work of Dr. Doris Taylor. Two years ago, the star university scientist drew international attention for successfully growing — and keeping alive — a beating rat’s heart in a jar. Taylor’s work fueled hopes that scientists can one day grow replacement organs for patients who would typically wait for transplants.

[Read more of this report]


University of Minnesota organ transplant spin-off moves closer to reality

The company, which is developing a way to grow transplant organs in labs, has no offices or Web site yet, but it’s a safe bet that Miromatrix will remain in Minnesota.

[Read more of this report]


« Newer Posts

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Jobs Board


MedCity Whitepapers

Real Time Web Analytics